Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21883Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zoras, O. | en |
| dc.contributor.author | Batsis, C. | en |
| dc.date.accessioned | 2015-11-24T19:18:37Z | - |
| dc.date.available | 2015-11-24T19:18:37Z | - |
| dc.identifier.issn | 1534-4681 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21883 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adenocarcinoma/*drug therapy | en |
| dc.subject | Antineoplastic Combined Chemotherapy Protocols/*therapeutic use | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Pancreatic Neoplasms/*drug therapy | en |
| dc.title | Erlotinib and pancreatic adenocarcinoma: uncertainty and hope | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1245/s10434-011-1809-x | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21630121 | - |
| heal.identifier.secondary | http://www.springerlink.com/content/u7k5583n383r3t03/fulltext.pdf | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2011 | - |
| heal.journalName | Ann Surg Oncol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Zoras-2011-Erlotinib and pancre.pdf | 126.38 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
